Best 52 Week Nasdaq Low Stocks to Buy in January 27, 2025
| Number | Ticker | Exchange | Market Cap | Price | 52 Weeks Low | 52 Weeks High | Analyst Decision |
|---|---|---|---|---|---|---|---|
| 1 | Nasdaq | $260.8B | $95.56 | $94.48 | $134.63 | Buy | |
| 2 | Nasdaq | $110.0B | $675.79 | $666.25 | $1,211.20 | Buy | |
| 3 | Nasdaq | $77.6B | $57.42 | $55.97 | $77.20 | Buy | |
| 4 | Nasdaq | $30.6B | $116.56 | $115.21 | $168.50 | Buy | |
| 5 | Nasdaq | $27.2B | $54.50 | $53.10 | $85.16 | Buy | |
| 6 | Nasdaq | $20.9B | $30.52 | $30.13 | $37.80 | Buy | |
| 7 | Nasdaq | $13.9B | $34.57 | $33.75 | $41.41 | Buy | |
| 8 | Nasdaq | $12.2B | $77.19 | $75.75 | $114.92 | Buy | |
| 9 | Nasdaq | $9.6B | $33.48 | $33.18 | $41.78 | Buy | |
| 10 | Nasdaq | $6.1B | $108.96 | $107.59 | $156.34 | Buy | |
| 11 | Nasdaq | $6.1B | $90.30 | $88.60 | $141.15 | Buy | |
| 12 | Nasdaq | $3.9B | $70.81 | $69.29 | $97.97 | Strong Buy | |
| 13 | Nasdaq | $3.7B | $62.77 | $60.96 | $87.67 | Buy | |
| 14 | Nasdaq | $3.5B | $17.15 | $16.83 | $27.27 | Strong Buy | |
| 15 | Nasdaq | $2.8B | $13.46 | $13.22 | $18.05 | Buy | |
| 16 | Nasdaq | $2.7B | $46.48 | $45.43 | $84.67 | Buy | |
| 17 | Nasdaq | $1.7B | $10.21 | $9.95 | $23.20 | Buy | |
| 18 | Nasdaq | $1.5B | $25.91 | $25.52 | $49.25 | Buy | |
| 19 | Nasdaq | $1.4B | $8.53 | $8.46 | $13.05 | Strong Buy | |
| 20 | ORKAOruka Therapeutics Inc. Common Stock | Nasdaq | $1.0B | $12.19 | $11.95 | $53.88 | Strong Buy |
| 21 | Nasdaq | $817.0M | $16.62 | $16.37 | $24.71 | Buy | |
| 22 | BMRNBioMarin Pharmaceutical Inc. | Nasdaq | N/A | $61.73 | $60.63 | $94.85 | Buy |
Share on Social Networks:
Disclaimer
The FinQuota filters have identified what they believe to be the "Best 52 Week Low Nasdaq Stocks to Buy Today" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.